CELH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Buy now as a tactical entry: CELH is trading near key support (~50 area) while short-term momentum is oversold, setting up a rebound attempt.", "Options positioning is notably call-leaning (put/call ratios below 1), aligning with a bullish near-term sentiment backdrop into the 2/27 earnings event.", "Wall Street tone has turned more constructive again in January (multiple Top Pick/Overweight reiterations and price-target raises), which can support dip-buying demand."]
["Trend/Momentum: Bearish momentum remains in force (MACD histogram -0.738 and negatively expanding), indicating the down-move hasn\u2019t fully reversed yet.", "Oversold: RSI(6) 24.84 is oversold, which often precedes short-term bounces\u2014especially when price is pressing support.", "Moving averages: Converging MAs suggest the prior trend is losing strength, but not yet a confirmed uptrend.", "Key levels: Price (50.25 pre-market) is below S1 (50.816) and above S2 (49.05); a reclaim of Pivot (53.675) would be the first meaningful upside confirmation, with resistance at 56.535 then 58.301.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: No signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Upcoming earnings catalyst: QDEC 2025 earnings on 2026-02-27 (pre-market) can act as a near-term re-rating trigger if results/guide are strong.", "Distribution/scale narrative: Analysts cite benefits from expanded PepsiCo partnership and improved category positioning (\u201ccategory captaincy\u201d), supporting 2026 expectations.", "Integration progress: Street commentary suggests the Alani Nu transition appears to be smoothing out, which could unlock incremental distribution opportunities through the year.", "Analyst tone improving: Multiple January \u201cTop Pick\u201d/Overweight reiterations and price-target raises can support sentiment and dip-buying."]
["Price action still weak: MACD worsening signals bearish momentum is still active; the stock may need more time to base.", "Execution risk: Prior notes highlighted Alani Nu integration and margin/mix headwinds (e.g., Rockstar margins) as near-term drags\u2014could resurface in guidance.", "Analyst disagreement: BofA remains Underperform with a $45 target, reflecting a credible bear case on fundamentals/valuation dispersion."]
["Latest quarter (2025/Q3): Revenue grew to $725.1M (+172.85% YoY), showing strong top-line expansion.", "Profitability: Net income was -$70.7M (still a loss), and EPS was -$0.27, indicating growth has not yet translated into consistent profitability.", "Margins: Gross margin improved to 51.34% (+11.63% YoY), a constructive trend that supports the bull case if it persists through the distribution transition."]
["Recent trend: December saw several price-target trims (integration/margin headwinds narrative), but January shifted back bullish with multiple Top Pick calls and price-target raises.", "Latest bullish updates: JPMorgan Overweight raised PT to $77 (from $68); Piper Sandler Overweight raised PT to $65 (from $61); BNP Paribas Top Pick/Outperform PT $67; Needham Top Pick Buy PT $70.", "Bear/neutral views: BofA maintains Underperform with PT $45; KeyBanc initiated at Sector Weight (wait-and-see on integration).", "Wall Street pros: Strong category tailwinds, scaling distribution via PepsiCo, potential upside to estimates as integration normalizes.", "Wall Street cons: Near-term noise from integration/mix and margin uncertainty; some argue upside is more limited after prior run-ups."]
